ERK-mediated phosphorylation of TFAM downregulates mitochondrial transcription: Implications for Parkinson's disease
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Mitochondrial transcription factor A (TFAM) regulates mitochondrial biogenesis, which is downregulated by extracellular signal-regulated protein kinases (ERK1/2) in cells treated chronically with the complex I inhibitor 1-methyl-4-phenylpyridinium (MPP+). We utilized mass spectrometry to identify ERK1/2-dependent TFAM phosphorylation sites. Mutation of TFAM at serine 177 to mimic phosphorylation recapitulated the effects of MPP+ in decreasing the binding of TFAM to the light strand promoter, suppressing mitochondrial transcription. Mutant TFAM was unable to affect respiratory function or rescue the effects of MPP+ on respiratory complexes. These data disclose a novel mechanism by which ERK1/2 regulates mitochondrial function through direct phosphorylation of TFAM.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer cell metabolism: warburg and beyond
Hsu, P. P., & Sabatini, D. M. (2008) · Cell · doi:10.1016/j.cell.2008.08.021 · Cited by 2,452 · cited 1×
“In particular, downregulation of mitochondrial respiration are hallmarks of neoplastic transformation and neurodegenerative diseases (Hsu and Sabatini, 2008; Johri and Beal, 2012).”
BackgroundMitochondrial Dysfunction in Neurodegenerative Diseases
Johri, A., & Beal, M. F. (2012) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.192138 · Cited by 806 · cited 1×
“In particular, downregulation of mitochondrial respiration are hallmarks of neoplastic transformation and neurodegenerative diseases (Hsu and Sabatini, 2008; Johri and Beal, 2012).”
BackgroundProgressive parkinsonism in mice with respiratory-chain-deficient dopamine neurons
Ekstrand, M. I., Terzioglu, M., Galter, D., Zhu, S., Hofstetter, C., Lindqvist, E., Thams, S., Bergstrand, A., Hansson, F. S., Trifunovic, A., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605208103 · Cited by 605 · cited 2×
“, 2012), most tissues in conditional TFAM knockout mice exhibit detrimental phenotypes accompanied by impaired mitochondrial function (Ekstrand et al., 2007; Li et al., 2000; Silva et al., 2000).”
BackgroundSilva, J. P., Köhler, M., Graff, C., Oldfors, A., Magnuson, M. A., Berggren, P.-O., & Larsson, N.-G. (2000) · Nature Genetics · doi:10.1038/81649 · Cited by 433
Vernochet, C., Mourier, A., Bezy, O., Macotela, Y., Boucher, J., Rardin, M. J., An, D., Lee, K. Y., Ilkayeva, O. R., Zingaretti, C. M., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.10.016 · Cited by 245 · cited 2×
“With the exception of a beneficial effect on obesity and insulin resistance (Vernochet et al., 2012), most tissues in conditional TFAM knockout mice exhibit detrimental phenotypes accompanied by impaired mitochondrial function (Ekstrand et al., 2007; Li et al., 2000; Silva et al., 2000).”
BackgroundGenetic modification of survival in tissue-specific knockout mice with mitochondrial cardiomyopathy
Li, H., Wang, J., Wilhelmsson, H., Hansson, A., Thorén, P., Duffy, J., Rustin, P., & Larsson, N.-G. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.7.3467 · Cited by 185 · cited 2×
“, 2012), most tissues in conditional TFAM knockout mice exhibit detrimental phenotypes accompanied by impaired mitochondrial function (Ekstrand et al., 2007; Li et al., 2000; Silva et al., 2000).”
BackgroundSpelbrink, J. N. (2010) · IUBMB Life · doi:10.1002/iub.282 · Cited by 171 · cited 1×
“The mitochondrial transcription factor A (TFAM) is one of the central regulatory components of mitochondrial nucleoids (Spelbrink, 2010).”
Background
Cited by
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 1
Klionsky, D. J., Abdel-Aziz, A. K., Abdelfatah, S., Abdellatif, M., Abdoli, A., Abel, S., Abeliovich, H., Abildgaard, M. H., Abudu, Y. P., Acevedo-Arozena, A., et al. (2021) · Autophagy · doi:10.1080/15548627.2020.1797280 · Cited by 2,897
Self-citationCompromised MAPK signaling in human diseases: an update
Kim, E. K., & Choi, E.-J. (2015) · Archives of Toxicology · doi:10.1007/s00204-015-1472-2 · Cited by 1,020
Excitotoxicity, calcium and mitochondria: a triad in synaptic neurodegeneration
Verma, M., Lizama, B. N., & Chu, C. T. (2022) · Translational Neurodegeneration · doi:10.1186/s40035-021-00278-7 · Cited by 451
Self-citationThe mitochondrial transcription factor TFAM in neurodegeneration: emerging evidence and mechanisms
Kang, I., Chu, C. T., & Kaufman, B. A. (2018) · FEBS Letters · doi:10.1002/1873-3468.12989 · Cited by 324
Self-citationRegulation of mitochondrial biogenesis through TFAM–mitochondrial DNA interactions
Picca, A., & Lezza, A. M. S. (2015) · Mitochondrion · doi:10.1016/j.mito.2015.10.001 · Cited by 283
Metadata
- Authors
- Wang, K. Z. Q., Zhu, J., Dagda, R. K., Uechi, G., Cherra, S. J., Gusdon, A. M., Balasubramani, M., & Chu, C. T.
- Venue
- Mitochondrion
- Publisher
- Elsevier BV
- Published
- 2014-07
- Volume
- 17
- Pages
- 132-140
- ISSN
- 1567-7249 (ISSN-L)
- OpenAlex
- W2009345535
- Cited by
- 73
- References
- 7
- FWCI
- 2.43
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.